Perspective Therapeutics Inc (CATX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Perspective Therapeutics Inc Stock (CATX) Company Profile

Perspective Therapeutics Inc

Healthcare (1079)

Medical Devices (140)

509-375-1202

350 Hills Street, Suite 106, Richland

Prossima data di guadagno

Ultimi documenti SEC

CATX's Discussions on Twitter

Compare CATX vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CATX Perspective Therapeutics Inc	2.89	321.61M	618.00K	-111.65M	-107.53M	-1.396
ABT Abbott Laboratories	105.74	182.00B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	325.74	129.09B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	85.40	107.81B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	46.73	67.64B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.03	47.81B	6.30B	1.07B	1.09B	1.8406

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-19	Iniziato	Piper Sandler	Overweight
2025-11-24	Ripresa	Truist	Buy
2025-10-10	Iniziato	BTIG Research	Buy
2025-03-13	Iniziato	H.C. Wainwright	Buy
2025-03-07	Iniziato	Scotiabank	Sector Outperform
2024-11-25	Downgrade	BofA Securities	Buy → Neutral
2024-10-24	Iniziato	UBS	Buy
2024-10-01	Iniziato	Wedbush	Outperform
2024-09-25	Iniziato	Truist	Buy
2024-07-25	Iniziato	BofA Securities	Buy
2024-05-09	Iniziato	Cantor Fitzgerald	Overweight

Mostra tutto

Perspective Therapeutics Inc Borsa (CATX) Ultime notizie

Perspective Therapeutics Inc Azioni (CATX) Dati Finanziari

Perspective Therapeutics Inc Azioni (CATX) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Williamson Robert F III	Director	Nov 12 '25	Buy	2.10	9,498	19,946	9,864

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc Stock (CATX) Company Profile

Compare CATX vs ABT, SYK, MDT, BSX, EW

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Perspective Therapeutics Inc Borsa (CATX) Ultime notizie

Perspective Therapeutics Inc (CATX) Balance Sheet - TradingKey

Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [²¹²Pb]VMT-α-NET in GEP-NETs - Quiver Quantitative

CATX|Perspective Therapeutics Inc|Price:2.820|Chg%:-0.090 - TradingKey

Perspective Therapeutics Inc (CATX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Perspective Therapeutics Inc (CATX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Perspective Therapeutics Inc (CATX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Perspective Therapeutics Market Sentiment - Benzinga España

Perspective Therapeutics Inc (CATX) Cash Flow - TradingKey

Perspective Therapeutics Inc (CATX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Perspective Therapeutics Inc - TradingKey

Perspective Therapeutics, Inc. Revenue Breakdown – TRADEGATE:AAJ0 - TradingView

BTIG reiterates Perspective Therapeutics stock rating on manufacturing edge - Investing.com

Perspective Therapeutics Inc (CATX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Perspective Therapeutics Dips 0.67% as Stock Hovers Near Support ZoneFair Value Gap - dars.gov.et

Perspective Therapeutics (CATX) gains 5.3% beneficial holder led by Millennium - Stock Titan

Perspective Therapeutics (CATX) Bank of America Global Healthcare Conference 2026 summary - Quartr

Perspective Therapeutics (CATX) RBC Capital Markets Global Healthcare Conference 2026 summary - Quartr

Perspective Therapeutics (CATX) Morgan Stanley 22nd Annual Global Healthcare Conference summary - Quartr

Perspective Therapeutics to present updated can... - Pluang

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026 - The Manila Times

Perspective Therapeutics Announces ESMO 2026 Presentation of Updated [212Pb]VMT-α-NET Data in Advanced Neuroendocrine Tumors - Quiver Quantitative

Perspective's cancer-treatment data gets ESMO oral presentation Oct. 23 - Stock Titan

Is Perspective Therapeutics, Inc. (CATX) stock outpacing its medical peers this year? - MSN

Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Perspective Therapeutics (CATX) Slides Over 5% as Support Levels Come into FocusOutside Reversal - dars.gov.et

CATX: Key Management Meeting Insights from BTIG Analyst - GuruFocus

symbol__ Stock Quote Price and Forecast - CNN

Perspective Therapeutics, Inc. Announces Executive Changes - marketscreener.com

Perspective Therapeutics Names Paul Lyne Chief Science Officer as Co-Founder Michael Schultz Moves to Advisory Role - marketscreener.com

Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor - The Manila Times

Perspective Therapeutics (CATX) Barclays 27th Annual Global Healthcare Conference summary - Quartr

Perspective Therapeutics (CATX) 2024 Cantor Fitzgerald Global Healthcare Conference summary - Quartr

Perspective Therapeutics (CATX) Q4 2025 earnings summary - Quartr

Perspective Therapeutics (CATX) Proxy filing Summary - Quartr

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Tenaya Therapeutics (TNYA) - The Globe and Mail

Perspective Therapeutics (CATX) UBS Global Healthcare Conference Summary - Quartr

CATX Q1 2026 Earnings: Narrower Loss Beats Expectations as Pipeline Progress ContinuesRevenue Growth Report - dars.gov.et

Piper Sandler Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Maintains Target Price $16 - Moomoo

Perspective Therapeutics Expands Radiopharmaceutical Pipeline to Target Brain Tumors - sekbernews.id

Perspective Therapeutics (CATX) Reports Encouraging Early Data Across Multiple Radiopharmaceutical Trials - Yahoo Finance

Perspective Therapeutics (CATX) Surges 4.9% as Bullish Momentum Tests Key ResistanceBPI Bull Confirmed - DonanımHaber

Perspective Therapeutics Advances Next-Generation 212Pb Radiopharmaceuticals for Solid Tumor Treatment and Melanoma - Minichart

Perspective Therapeutics Highlights Progress in Alpha Radiopharmaceutical Pipeline - TipRanks

Perspective Therapeutics (CATX) updates radiopharmaceutical oncology pipeline presentation - Stock Titan

Millennium reports 4.89M shares (4.3%) in Perspective Therapeutics | CATX SEC FilingForm SCHEDULE 13G - Stock Titan

CATX: Analyst Engages with Management in Virtual Discussion - GuruFocus

Perspective Therapeutics, Inc. Actuals & Estimates (AMEX:CATX) - TradingView

Perspective Therapeutics, Inc. Actuals & Estimates (TRADEGATE:AAJ0) - TradingView

Enterprise value to revenue forward of Perspective Therapeutics, Inc. – AMEX:CATX - TradingView

Price to earnings forward of Perspective Therapeutics, Inc. – AMEX:CATX - TradingView

CATX Forecast — Price Target — Prediction for 2027 - TradingView

Perspective Therapeutics Inc Azioni (CATX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Perspective Therapeutics Inc Azioni (CATX) insider trading

Simile a CATX